SEC Form 4 · accession 0001144204-15-041324
VACCINOGEN INC · VGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Tussing
Officer — See Remarks · Director
Period of report
Apr 29, 2015
Accepted (ET)
Jul 7, 2015 · 11:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453001
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy)F1 | $1.00 | Apr 29, 2015 | D | 20,575 | D | — | Feb 28, 2015 | Common Stock | 20,575 | 0 | D |
| Warrant (right to buy)F1 | $1.00 | Apr 29, 2015 | A | 20,575 | A | — | Feb 28, 2016 | Common Stock | 20,575 | 20,575 | D |
Explanation of responses
- F1The two reported transactions involved an amendment to an outstanding purchase warrant that extended the expiration date, resulting in the deemed cancellation of the "old" purchase warrant and the grant of a replacement purchase warrant. The purchase warrant was originally granted on June 1, 2008 and is exercisable, in whole or in part, at any time after the date of grant.
Remarks
CEO, President, CFO, Treasurer, COO and Secretary